These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34168449)

  • 41. Erratum: Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification [Corrigendum].
    Int J Nanomedicine; 2019; 14():7363. PubMed ID: 31686811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erratum: Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum].
    Int J Nanomedicine; 2019; 14():9793. PubMed ID: 31849469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erratum: Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum].
    Int J Nanomedicine; 2020; 15():6561-6562. PubMed ID: 32982217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erratum: Preparation of Brushite Cements with Improved Properties by Adding Graphene Oxide [Corrigendum].
    Int J Nanomedicine; 2020; 15():3121. PubMed ID: 32547007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erratum: Application of Radiosensitizers in Cancer Radiotherapy [Corrigendum].
    Int J Nanomedicine; 2021; 16():8139-8140. PubMed ID: 34949921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erratum: Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum].
    Int J Nanomedicine; 2021; 16():7283-7284. PubMed ID: 34737565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erratum: Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum].
    Int J Nanomedicine; 2021; 16():5099. PubMed ID: 34349509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erratum: Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin
    Int J Nanomedicine; 2020; 15():9669-9670. PubMed ID: 33299311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erratum: Understanding Greater Cardiomyocyte Functions on Aligned Compared to Random Carbon Nanofibers in PLGA [Corrigendum].
    Int J Nanomedicine; 2021; 16():4193. PubMed ID: 34188468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erratum: Development and Optimization of Terpene-Enriched Vesicles (Terpesomes) for Effective Ocular Delivery of Fenticonazole Nitrate: In vitro Characterization and in vivo Assessment [Corrigendum].
    Int J Nanomedicine; 2022; 17():3509-3510. PubMed ID: 35966147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erratum: A Cleverly Designed Novel Lipid Nanosystem: Targeted Retention, Controlled Visual Drug Release, and Cascade Amplification Therapy for Mammary Carcinoma in vitro [Corrigendum].
    Int J Nanomedicine; 2020; 15():6089-6091. PubMed ID: 32884265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erratum: Carbon Nanotubes Impregnated with Subventricular Zone Neural Progenitor Cells Promotes Recovery from Stroke [Corrigendum].
    Int J Nanomedicine; 2021; 16():5185. PubMed ID: 34354351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erratum: Comparative Analysis of Commercial Colloidal Silver Products [Corrigendum].
    Int J Nanomedicine; 2022; 17():553-554. PubMed ID: 35153480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erratum: Oral Administration of Encapsulated Bovine Lactoferrin Protein Nanocapsules Against Intracellular Parasite
    Int J Nanomedicine; 2020; 15():6871-6872. PubMed ID: 32982238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erratum: Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum].
    Int J Nanomedicine; 2019; 14():7919. PubMed ID: 31632008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erratum: A two-layer skin construct consisting of a collagen hydrogel reinforced by a fibrin-coated polylactide nanofibrous membrane [Corrigendum].
    Int J Nanomedicine; 2019; 14():7215. PubMed ID: 31564874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erratum: Targeting EZH2 for glioma therapy with a novel nanoparticle-siRNA complex [Corrigendum].
    Int J Nanomedicine; 2019; 14():6587-6588. PubMed ID: 32461716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erratum: Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum].
    Int J Nanomedicine; 2020; 15():5179. PubMed ID: 32801684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erratum: Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum].
    Int J Nanomedicine; 2021; 16():7495-7496. PubMed ID: 34785896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erratum: Implementation of PPI with Nano Amorphous Oxide Semiconductor Devices for Medical Applications [Corrigendum].
    Int J Nanomedicine; 2020; 15():9497-9498. PubMed ID: 33281444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.